NCT03846128 2026-04-14
BIOSUNTOX
University Hospital, Rouen
Terminated
Clinical Trials
125 trialsNCT06026332 2026-02-17
ABLE-41
Ferring Pharmaceuticals
Terminated
NCT02125617 2026-01-14
uPARCRPC
Rigshospitalet, Denmark
Terminated
NCT06347809 2025-12-15
DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
Mayo Clinic
Terminated
NCT04412070 2025-11-21
ALU
Hopital Foch
Terminated
NCT03503097 2025-10-01
GENTleMEN
University of Washington
Terminated
NCT01563796 2025-09-26
Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
Medical Diagnostic Laboratories, LLC
Terminated
NCT04996849 2025-09-24
Contemporary Characteristics of Penile Cancer
M.D. Anderson Cancer Center
Terminated
NCT07117409 2025-09-11
RI-NIVO
Azienda USL Reggio Emilia - IRCCS
Terminated
NCT03485794 2025-08-12
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer
University of Southern California
Terminated
NCT05611307 2025-08-11
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Indiana University
Terminated
NCT06264479 2025-07-30
PEAR-TREE2
Ourotech, Inc.
Terminated
NCT06655064 2025-07-14
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
Telix Pharmaceuticals (Innovations) Pty Limited
Terminated
NCT05872503 2025-07-10
Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy
National Institutes of Health Clinical Center (CC)
Terminated
NCT01231932 2025-06-19
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
National Institutes of Health Clinical Center (CC)
Terminated
NCT06421311 2025-06-05
URADJ
Bristol-Myers Squibb
Terminated
NCT03076242 2025-04-29
Genetic Evaluation of Men (GEM)
Thomas Jefferson University
Terminated
NCT03197948 2025-04-29
Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment
Thomas Jefferson University
Terminated
NCT05819827 2025-04-27
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Terminated
NCT06375629 2025-04-02
ES-HIFU
EDAP TMS S.A.
Terminated
NCT05208229 2025-04-01
WB-LuPSMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Terminated
NCT02053662 2025-03-21
Biomarker Identification for Bladder Cancer Patients
Ohio State University Comprehensive Cancer Center
Terminated
NCT02538809 2025-02-13
Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals
Swiss Paraplegic Research, Nottwil
Terminated
NCT05534789 2025-01-20
Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).
Pfizer
Terminated
NCT05709535 2024-12-18
PSMA-PET/CT Registry
AHS Cancer Control Alberta
Terminated
NCT04293406 2024-07-31
pCHIP: Prostate Cancer Health Impact Program
Weill Medical College of Cornell University
Terminated
NCT03134027 2024-07-18
Immune PDX
Duke University
Terminated
NCT03140176 2024-05-10
OPTIMISE
Pfizer
Terminated
NCT04927559 2024-04-29
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
University of Southern California
Terminated
NCT05699135 2024-04-24
TRAVELER
Pfizer
Terminated
NCT05169372 2024-02-21
PET-PSMA
Latin American Cooperative Oncology Group
Terminated
NCT04234399 2024-01-24
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy
University of Vermont
Terminated
NCT01117779 2024-01-19
TRACE
Boston Scientific Corporation
Terminated
NCT03709771 2024-01-12
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
Vanderbilt University Medical Center
Terminated
NCT05301062 2023-09-22
CREDIT
Bayer
Terminated
NCT04106167 2023-09-21
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Terminated
NCT05437679 2023-09-05
CHARTER
Angle plc
Terminated
NCT05568407 2023-07-13
A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer
Pfizer
Terminated
NCT04873427 2023-02-15
In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies
Clinica Luganese Moncucco
Terminated
NCT04147143 2022-12-23
CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Terminated
NCT05052372 2022-12-22
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
xCures
Terminated
NCT02735512 2022-08-10
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
University of Southern California
Terminated
NCT03553732 2022-08-04
An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital
University of California, San Francisco
Terminated
NCT03755492 2022-07-21
Initiative to Minimize Disparities in Postoperative Prostate Cancer Care
Albert Einstein Healthcare Network
Terminated
NCT03290508 2022-06-23
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
Myriad Genetic Laboratories, Inc.
Terminated
NCT02365883 2022-06-14
Transrectal Photoacoustic Imaging of the Prostate
Stanford University
Terminated
NCT03152448 2022-06-13
P-PROVE
Myriad Genetic Laboratories, Inc.
Terminated
NCT02164942 2022-04-26
LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer
Wake Forest University Health Sciences
Terminated
NCT04357717 2022-03-31
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting
Exosome Diagnostics, Inc.
Terminated
NCT04960956 2022-03-14
Glycosylation of Exosomes in Prostate and Urothelial Carcinoma
Indiana University
Terminated